| abstract |
An antimycotic drug composition excellent in stability and usable particularly as a preparation for injection, containing an imidazol-1-yl or 1,2,4-triazol-1-yl compound which has a nitrogen atom quaternized with a group represented by general formula (II): (wherein R1 is a hydrocarbon or heterocyclic group which may be substituted; R2 is hydrogen or lower alkyl; and n is 0 or 1) and can be converted into an antimycotic azole compound in vivo through the elimination of the group, and a saccharide. |